GlassScriptPhysician profile
Amber L Mclean
NPI 1295917334
$1,268.14
in general payments reported to CMS, 2019-2025
20 companies · $56.81 in 2025
The $56.81 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.92 · 2020: $268 · 2021: $294 · 2022: $281 · 2023: $176 · 2024: $101 · 2025: $56.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $333.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $253.89 | 2019-2023 | |
| Daiichi Sankyo INC. | $140.49 | 2019-2024 | Vanflyta |
| Pfizer INC. | $107.74 | 2020-2024 | |
| Therapeuticsmd, INC. | $91.51 | 2019-2022 | |
| Aspira Women'S Health INC | $89.24 | 2021-2023 | Ova1 |
| Coopersurgical, INC. | $85.41 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Myovant Sciences INC. | $68.34 | 2021-2022 | |
| Applied Medical Resources Corporation | $65.96 | 2022 | |
| Hologic Sales and Service, LLC | $63.13 | 2022-2025 | Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Bayer Healthcare Pharmaceuticals INC. | $55.83 | 2020-2025 | |
| Astellas Pharma US INC | $51.94 | 2022-2024 | Veozah |
| Minerva Surgical, INC | $45.02 | 2021 | |
| Exeltis, USA INC. | $41.22 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $22.96 | 2019-2020 | |
| Lilly USA, LLC | $16.93 | 2025 | Mounjaro, Zepbound |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alydia Health | $16.12 | 2021 | |
| Evofem Biosciences, INC. | $14.45 | 2021 | |
| Covidien LP | $13.50 | 2019 | |
| Mylan Pharmaceuticals INC. | $13.46 | 2021 | |
| Merck Sharp & Dohme LLC | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Mclean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.